ISG15 and protein ISGylation in innate immune responses

被引:0
|
作者
Zhang, Dong-Er [1 ]
机构
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
关键词
D O I
10.1016/j.cyto.2008.07.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:234 / 234
页数:1
相关论文
共 50 条
  • [1] ISG15 and protein ISGylation
    Cong, Xiuli
    Reuter, Brian
    Yan, Ming
    Zhang, Dong-Er
    [J]. CYTOKINE, 2010, 52 (1-2) : 80 - 80
  • [2] Antiviral Activity of Innate Immune Protein ISG15
    Harty, Ronald N.
    Pitha, Paula M.
    Okumura, Atsushi
    [J]. JOURNAL OF INNATE IMMUNITY, 2009, 1 (05) : 397 - 404
  • [3] ISG15 and ISGylation in Human Diseases
    Mirzalieva, Oygul
    Juncker, Meredith
    Schwartzenburg, Joshua
    Desai, Shyamal
    [J]. CELLS, 2022, 11 (03)
  • [4] The Functional Roles of ISG15/ISGylation in Cancer
    Yuan, Yin
    Qin, Hai
    Li, Huilong
    Shi, Wanjin
    Bao, Lichen
    Xu, Shengtao
    Yin, Jun
    Zheng, Lufeng
    [J]. MOLECULES, 2023, 28 (03):
  • [5] UBP43 and ISG15 in the Innate Immune Response
    Zhang, Dong
    [J]. CYTOKINE, 2009, 48 (1-2) : 30 - 30
  • [6] Nitrosylation of ISG15 prevents the disulfide bond-mediated dimerization of ISG15 and contributes to effective ISGylation
    Okumura, Fumihiko
    Lenschow, Deborah J.
    Zhang, Dong-Er
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (36) : 24484 - 24488
  • [7] Consecutive Inhibition of ISG15 Expression and ISGylation by Cytomegalovirus Regulators
    Kim, Ye Ji
    Kim, Eui Tae
    Kim, Young-Eui
    Lee, Myoung Kyu
    Kwon, Ki Mun
    Kim, Keun Il
    Stamminger, Thomas
    Ahn, Jin-Hyun
    [J]. PLOS PATHOGENS, 2016, 12 (08)
  • [8] ISG15 and ISGylation: Emergence in the cytoskeleton dynamic and tumor microenvironment
    Tecalco-Cruz, Angeles C.
    [J]. BIOCELL, 2022, 46 (05) : 1209 - 1213
  • [9] ISG15 and immune diseases
    Jeon, Young Joo
    Yoo, Hee Min
    Chung, Chin Ha
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (05): : 485 - 496
  • [10] Free ISG15 and Protein ISGylation Emerging in SARS-CoV-2 Infection
    Tecalco Cruz, Angeles C.
    [J]. CURRENT DRUG TARGETS, 2022, 23 (07) : 686 - 691